Status:
TERMINATED
Study Evaluation LXR-623 in Healthy Adults
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy Subjects
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
To evaluate the safety and tolerability of multiple doses of LXR in healthy adults.
Eligibility Criteria
Inclusion
- Generally healthy adults.
- Liver function tests, triglycerideres, and creatinine must be below upper limit of normal at screening.
Exclusion
- A history or active presence of clinically important medical disease.
- Any metal implants or devices.
- Claustrophobia.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00379860
Start Date
October 1 2006
End Date
January 1 2007
Last Update
March 9 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.